Ann: Dimerix and Taiba enter into License Agreement for DMX-200, page-100

Hey Everyone & Firelines,

I saw that ANN as well & it changes nothing that wasn’t originally out there. It was based on milestones being met, it was a long time ago, I think 2020 regarding those unlisted options? I am still dealing with a snotfest here & a sick kid at the moment, so look at the Webinar later.

Some huge progress here with DXB & step by step, happy with what we have.

As for India, it’s a huge space for pharmaceutical ls & generics, I think that will depend on our patents, and also the need in India for CKD sufferers (massive, especially DKD). The need for dialysis is overwhelming, spent quite a lot of time reading up on that previously.

@UncleFester, you are right, as is @singhgu, International work opportunities have made a huge difference, a tablet is a big difference to an infusion for Govt costs to finance. Maybe we are all the t middle class working poor now, including here in Australia?

At least we have Medicare. Have a fabulous day everyone.